UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

B Acquisition builds on UCB’s 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying therapies. Lead investigational asset,…
posteditor
posteditor
Articles: 16137

Other News